Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=40091458&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR7658(A)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp, Merck Sharp & DohmefiledCriticalSchering Corp
Priority to CR7658ApriorityCriticalpatent/CR7658A/en
Publication of CR7658ApublicationCriticalpatent/CR7658A/en
La presente invencion proporciona una composicion farmaceutica que comprende un inhibidor de la absorcion de colesterol y un inhibidor de una HMG-CoA reductasa, con uno o mas antioxidantes, celuosa microcristalina, hidroxipropil metilcelulosa, estearato de magnesio y lactosa. La composicion no necesita contener acido ascorbico en orden de obtener la estabilidad deseable.The present invention provides a pharmaceutical composition comprising a cholesterol absorption inhibitor and an HMG-CoA reductase inhibitor, with one or more antioxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose. The composition does not need to contain ascorbic acid in order to obtain desirable stability.
CR7658A2005-01-192005-01-19
COMPOSITION INCLUDING A CHOLESTEROL ABSORPTION INHIBITOR A HMG-COA INHIBITOR AND A STABILIZING AGENT
CR7658A
(en)
Compounds derived from substituted pyrrolidines, inhibitors of factor xa and / or inhibitors on serine protease; pharmaceutical composition comprising said compounds; procedure to prepare the pharmaceutical composition; and use of the compounds to prepare a medicamneto with an antithrombotic effect